Susquehanna International Group, LLP Vericel Corp Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$42.25 - $53.56 $299,975 - $380,276	7,100 New	7,100 $299,000
Q1 2024 May 07, 2024	BUY	$32.52 - $52.33 $1.42 Million - $2.29 Million	43,700 Added 496.59%	52,500 $2.73 Million
Q4 2023 Feb 14, 2024	BUY	$30.85 - $37.09 $15,425 - $18,545	500 Added 6.02%	8,800 $313,000
Q3 2023 Nov 14, 2023	BUY	$31.69 - $39.25 $91,901 - $113,825	2,900 Added 53.7%	8,300 $278,000
Q2 2023 Aug 11, 2023	SELL	$29.0 - $38.37 $81,200 - $107,436	-2,800 Reduced 34.15%	5,400 $202,000
Q1 2023 May 16, 2023	BUY	$23.85 - $31.34 $195,570 - $256,988	8,200 New	8,200 $240,000

277

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.